• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Model Number GSX0025A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 12/16/2020
Event Type  Injury  
Event Description
It was reported to gore a 25mm gore® cardioform septal occluder was implanted on (b)(6) 2020 to treat a patent foramen ovale.During the one year follow-up visit on (b)(6) 2021, thrombus formation was noted on the left disc.No clinical sequelae were noted.The patient had been treated for six months post implant with aspirin and plavix, followed by aspirin alone.The patient was started on a full dose or oral anticoagulants and will have repeat imaging in six months.
 
Manufacturer Narrative
H6: code 4112 -imaging evalutaion.Due to the limited imaging provided it is difficult to assess the position of the device.There does appear to be a vegetation attached to the left atrial disc.Its appearance is consistent with that of thrombus.The cause of the thrombus cannot be ascertained from the imaging provided.
 
Manufacturer Narrative
H6: updated investigation findings.Added investigation conclusions code 22.Added component codes.The gore® cardioform septal occluder instructions for use states: adverse events associated with the use of the occluder may include but are not limited to: thrombosis or thromboembolic event resulting in clinical sequelae.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kathy titus
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13281087
MDR Text Key283949895
Report Number2017233-2022-02672
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132631025
UDI-Public00733132631025
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/21/2022
Device Model NumberGSX0025A
Device Catalogue NumberGSX0025A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/21/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age56 YR
Patient SexFemale
-
-